Patents Assigned to LivTech Inc.
  • Publication number: 20090299038
    Abstract: The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
    Type: Application
    Filed: March 16, 2009
    Publication date: December 3, 2009
    Applicant: LivTech Inc.
    Inventors: Koji Nakamura, Rie Tajima, Shankar Kumar, J. Yun Tso, Naoya Tsurushita